Vitality Biopharma Hires Investment Bank To Explore M&A, Asset Sale Opportunities

Drug development company Vitality Biopharma Inc. (OTCQB: VBIOhas tapped financial adviser DelMorgan & Co. to manage a potential sale process.

Neil Morganbesser, DelMorgan’s President and CEO, said “the right partner — either through M&A or a capital infusion — could be the key to unlocking Vitality’s explosive growth potential.”

Vitality’s portfolio consists of cannabinoid drugs and new treatments for Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).

Vitality CEO Michael Cavanaugh said he was “thrilled” that Santa Monica, California-based DelMorgan opted …

Full story available on Benzinga.com

More Vitality Biopharma Hires Investment Bank To Explore M&A, Asset Sale Opportunities